TheEdgeResearch
Home / Stocks / VANI

Vivani Medical, Inc. (VANI)

NASDAQ Healthcare Biotechnology
$1.37 ▼ -1.44%
Market Cap
$118.1M
Sector
Healthcare
Industry
Biotechnology
Beta
3.28
52-Wk Range
0.923-1.92
CEO
Adam Mendelsohn
Country
US
Currency
USD

Vivani Medical, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Alameda, CA, US. The stock last traded at $1.37, down 1.44% on the session, giving a market capitalisation of $118.1M. On trailing twelve-month figures it carries a trailing P/E of -3.43, a net margin of 0.0%. Its beta of 3.28 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.43
Price / Sales
0.00
Price / Book
5.83
EV / EBITDA
-4.38
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.96
Current ratio
3.18
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
42
IPO date
2014-11-19
Headquarters
Alameda, CA, US
About Vivani Medical, Inc.

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

Comparable companies

Vivani Medical, Inc. is most often compared with the following Healthcare names:

CRDLEDAPFONRHYPRIMAMBOTNSPRORMPQIPTRCEL
More research on VANI
VANI technical analysis VANI TheEdge Score Compare against peers
Open full interactive analysis & DCF →